Genistein supplementation improves some cardiovascular risk factors in postmenopausal women with Type 2 diabetes mellitus

Genistein supplementation improves some cardiovascular risk factors in postmenopausal women with Type 2 diabetes mellitus


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: حسن براخاص , مریم رف رف , سعادت کریمی , محمد اصغری جعفرآبادی

کلمات کلیدی: ype 2 diabetes mellitus,Genistein, postmenopausal ,cardiovascular risk factors

نشریه: 25875 , 10.1108/NFS-03-2020-0074 , 10.1108/NFS-03-2020-0074 , 2020

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله مریم رف رف
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات علوم تغذیه
کد مقاله 73654
عنوان فارسی مقاله Genistein supplementation improves some cardiovascular risk factors in postmenopausal women with Type 2 diabetes mellitus
عنوان لاتین مقاله Genistein supplementation improves some cardiovascular risk factors in postmenopausal women with Type 2 diabetes mellitus
ناشر 4
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

© 2020, Emerald Publishing Limited. Purpose: Type 2 diabetes mellitus (T2DM) is a worldwide health problem. Blood pressure (BP) and inflammation are well-established risk factors for the cardiovascular complications of T2DM. Genistein is known to improve endothelial dysfunction. The purpose of this study is to investigate the effects of genistein supplementation on BP, high-sensitive C-reactive protein (hs-CRP) and homocysteine (Hcy) levels in postmenopausal women with T2DM. Design/methodology/approach: This randomized, double-blind, placebo-controlled clinical trial is conducted on postmenopausal women with T2DM. A total of 54 subjects aged between 47 and 69 years are divided into two groups. Participants in the genistein group (n = 28) are given two genistein capsules (each capsule contained 54 mg genistein) and those in the placebo group (n = 26) received two placebo capsules (each capsule contained 54 mg maltodextrin) daily for 12 weeks. General characteristics, BP, hs-CRP and Hcy levels are measured at the baseline and at the end of the trial. Findings: Genistein supplementation resulted in a significant reduction in systolic BP (SBP) (p < 0.001), diastolic BP (DBP) (p = 0.020), mean arterial pressure (MAP) (p < 0.001), serum levels of hs-CRP (p = 0.005) and Hcy (p = 0.001) in genistein group compared with placebo group at the end of the study. Significant decreases are also found in SBP by 5.4%, p < 0.001, DBP by 6.7%, p < 0.001, MAP by 6.2%, p < 0.001, serum levels of hs-CRP by 47.0%, p = 0.015 and Hcy by 18.4%, p < 0.001 in the genistein supplemented group. No significant changes are observed in terms of all post-intervention values in the placebo group. Originality/value: Genistein administration improved BP, hs-CRP and Hcy levels in postmenopausal women with T2DM and may be useful in control of some CVD risk factors in these subjects

نویسندگان
hide/show

نویسنده نفر چندم مقاله
حسن براخاصاول
مریم رف رفدوم
سعادت کریمیسوم
محمد اصغری جعفرآبادیچهارم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Genistein supplementation.pdf1399/07/13181968دانلود